Affiliation:
1. Eaton Laboratories, Norwich Pharmacal Company, Norwich, New York 13815
Abstract
A rat
Proteus
and
Escherichia
pyelonephritis model is described in which (i) reproducible chronic infections are achieved and (ii) the efficacy of clinically effective agents is reliably demonstrable with five rats in 17 days. It can serve as a primary screen in which one technician can evaluate 180 compounds per month with 900 rats. The manner of inoculation will inherently allow the study of and distinction between metabolism which is peculiar to infection and that which is characteristic of trauma and healing in general for the elucidation of chemical correlations with effective therapy.
Publisher
American Society for Microbiology
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference9 articles.
1. Allen A. C. 1962. The kidney medical and surgical diseases p. 19 2nd ed. Grune and Stratton Inc. New York.
2. Pyelitis an important factor in the pathogenesis of retrograde pyelonephritis;Andersen B. R.;J. Exp. Med.,1961
3. Geographical distribution of urinary calculus;Anonymous;Brit. Med. J.,1965
4. Hematogenous pyelonephritis in rats. III. Relationship of bacterial species to the pathogenesis of acute pyelonephritis;Braude A. I.;J. Bacteriol.,1959
5. Colby F. H. 1961. Essential urology p. 363 4th ed. The Williams & Wilkins Co. Baltimore.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献